novo nordisk a/s-b (NOVB:Xetra)
Key News About novo nordisk a/s-b

| Recently Viewed | |||
| NOVB:GR | €120.30 EUR | -1.09 | |
| Company | Last | Change |
| AstraZeneca PLC | 3,241 GBp | -9.50 |
| Bristol-Myers Squibb Co | $46.05 USD | -0.80 |
| Eli Lilly & Co | $51.37 USD | -0.98 |
| Reckitt Benckiser Group PLC | 4,742 GBp | -6.00 |
| Takeda Pharmaceutical Co Ltd | ¥4,360 JPY | -90.00 |
| View Industry Companies | ||
Industry Analysis
NOVB
Industry Average
| Valuation | NOVB | Industry Range |
| Price/Earnings | 22.8x |
|
| Price/Sales | 6.4x |
|
| Price/Book | 15.1x |
|
| Price/Cash Flow | 18.4x |
|
| TEV/Sales | 5.1x |
|
Post a JobJobs
- Chicago, IL | DunnhumbyusaPosted: Jun 18
- Thomasville, GA | Flowers FoodsPosted: Jun 07
- San Francisco, CA | YelpPosted: Jun 06
- San Francisco, CA | PeoplematterPosted: Jun 06
Sponsored Financial Commentaries
Sponsored Links
To contact NOVO NORDISK A/S-B, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.








